UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early Detection of Nerve Fiber Loss by Corneal Confocal Microscopy and Skin Biopsy in Recently Diagnosed Type 2 Diabetes

Diabetes (New York, N.Y.), 2014-07, Vol.63 (7), p.2454-2463

2014

Volltextzugriff (PDF)

Detection of Mutant Free Circulating Tumor DNA in the Plasma of Patients with Gastrointestinal Stromal Tumor Harboring Activating Mutations of CKIT or PDGFRA

Clinical cancer research, 2013-09, Vol.19 (17), p.4854-4867

2013

Volltextzugriff (PDF)

Sequential Inhibitor Therapy in CML: In Vitro Simulation Elucidates the Pattern of Resistance Mutations after Second- and Third-Line Treatment

Clinical cancer research, 2013-06, Vol.19 (11), p.2962-2972

2013

Volltextzugriff (PDF)

FLT-PET Is Superior to FDG-PET for Very Early Response Prediction in NPM-ALK-Positive Lymphoma Treated with Targeted Therapy

Cancer research (Chicago, Ill.), 2012-10, Vol.72 (19), p.5014-5024

2012

Volltextzugriff (PDF)

The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion

Haematologica (Roma), 2012-05, Vol.97 (5), p.771-779

2012

Volltextzugriff (PDF)

SRC is a signaling mediator in FLT3-ITD– but not in FLT3-TKD–positive AML

Blood, 2012-04, Vol.119 (17), p.4026-4033

2012

Volltextzugriff (PDF)

Formylated Peptides Are Important Virulence Factors in Staphylococcus aureus Arthritis in Mice

The Journal of infectious diseases, 2012-01, Vol.205 (2), p.305-311

2012

Volltextzugriff (PDF)

The Virulence Regulator Agr Controls the Staphylococcal Capacity to Activate Human Neutrophils via the Formyl Peptide Receptor 2

Journal of innate immunity, 2012-01, Vol.4 (2), p.201-212

2012

Volltextzugriff (PDF)

Stromal pleiotrophin regulates repopulation behavior of hematopoietic stem cells

Blood, 2011-09, Vol.118 (10), p.2712-2722

2011

Volltextzugriff (PDF)

An RNAi-based system for loss-of-function analysis identifies Raf1 as a crucial mediator of BCR-ABL–driven leukemogenesis

Blood, 2011-08, Vol.118 (8), p.2200-2210

2011

Volltextzugriff (PDF)

Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis

Blood, 2011-02, Vol.117 (6), p.1817-1821

2011

Volltextzugriff (PDF)

Controlling Fibroblast Adhesion with Ph Modified Polyelectrolyte Multilayers

International journal of artificial organs, 2011-02, Vol.34 (2), p.185-191

2011

Volltextzugriff (PDF)

How can we reduce the number of coroner autopsies? Lessons from Scotland and the Dundee initiative

Journal of the Royal Society of Medicine, 2011-01, Vol.104 (1), p.19-24

2011

Volltextzugriff (PDF)

Oncogenic JAK2V617F requires an intact SH2-like domain for constitutive activation and induction of a myeloproliferative disease in mice

Blood, 2010-11, Vol.116 (22), p.4600-4611

2010

Volltextzugriff (PDF)

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

The New England journal of medicine, 2010-08, Vol.363 (8), p.711-723

2010

Volltextzugriff (PDF)

ADAM17 Regulates Epidermal Growth Factor Receptor Expression through the Activation of Notch1 in Non-Small Cell Lung Cancer

Cancer research (Chicago, Ill.), 2010-07, Vol.70 (13), p.5368-5378

2010

Volltextzugriff (PDF)

Antifungal Therapy with Itraconazole Impairs the Anti-Lymphoma Effects of Rituximab by Inhibiting Recruitment of CD20 to Cell Surface Lipid Rafts

Cancer research (Chicago, Ill.), 2010-06, Vol.70 (11), p.4292-4296

2010

Volltextzugriff (PDF)

Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2009-09, Vol.27 (25), p.4068-4075

2009

Volltextzugriff (PDF)

Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2823-2830

2009

Volltextzugriff (PDF)

Histone Deacetylase Inhibitors Induce a Very Broad, Pleiotropic Anticancer Drug Resistance Phenotype in Acute Myeloid Leukemia Cells by Modulation of Multiple ABC Transporter Genes

Clinical cancer research, 2009-06, Vol.15 (11), p.3705-3715

2009

Volltextzugriff (PDF)

FMS-Like Tyrosine Kinase 3―Internal Tandem Duplication Tyrosine Kinase Inhibitors Display a Nonoverlapping Profile of Resistance Mutations In vitro

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (7), p.3032-3041

2009

Volltextzugriff (PDF)

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

Cancer, 2009-02, Vol.115 (3), p.551-560

2009

Volltextzugriff (PDF)

Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy

Clinical cancer research, 2009-01, Vol.15 (2), p.460-467

2009

Volltextzugriff (PDF)

Imatinib and leptomycin B are effective in overcoming imatinib-resistance due to Bcr-Abl amplification and clonal evolution but not due to Bcr-Abl kinase domain mutation

Haematologica (Roma), 2008-11, Vol.93 (11), p.1718-1722

2008

Volltextzugriff (PDF)

GM1 Expression of Non-Hodgkin's Lymphoma Determines Susceptibility to Rituximab Treatment

Cancer research (Chicago, Ill.), 2008-07, Vol.68 (13), p.5414-5422

2008

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

KollektionPublisher website

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(66)

Sprache

Englisch
(66)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(66)
Life Sciences & Biomedicine
(56)
Science & Technology
(56)
Humans
(53)
Hematologic And Hematopoietic Diseases
(31)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(29)
Male
(29)
Female
(28)
Oncology
(24)
Pharmacology. Drug Treatments
(24)
Antineoplastic Agents
(23)
Middle Aged
(23)
Hematology
(21)
Aged
(20)
Animals
(18)
Adult
(17)
Mice
(16)
Tumors
(14)
Treatment Outcome
(12)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early Detection of Nerve Fiber Loss by Corneal Confocal Microscopy and Skin Biopsy in Recently Diagnosed Type 2 Diabetes

Detection of Mutant Free Circulating Tumor DNA in the Plasma of Patients with Gastrointestinal Stromal Tumor Harboring Activating Mutations of CKIT or PDGFRA

Sequential Inhibitor Therapy in CML: In Vitro Simulation Elucidates the Pattern of Resistance Mutations after Second- and Third-Line Treatment

FLT-PET Is Superior to FDG-PET for Very Early Response Prediction in NPM-ALK-Positive Lymphoma Treated with Targeted Therapy

The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion

SRC is a signaling mediator in FLT3-ITD– but not in FLT3-TKD–positive AML

Formylated Peptides Are Important Virulence Factors in Staphylococcus aureus Arthritis in Mice

The Virulence Regulator Agr Controls the Staphylococcal Capacity to Activate Human Neutrophils via the Formyl Peptide Receptor 2

Stromal pleiotrophin regulates repopulation behavior of hematopoietic stem cells

An RNAi-based system for loss-of-function analysis identifies Raf1 as a crucial mediator of BCR-ABL–driven leukemogenesis

Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis

Controlling Fibroblast Adhesion with Ph Modified Polyelectrolyte Multilayers

How can we reduce the number of coroner autopsies? Lessons from Scotland and the Dundee initiative

Oncogenic JAK2V617F requires an intact SH2-like domain for constitutive activation and induction of a myeloproliferative disease in mice

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

ADAM17 Regulates Epidermal Growth Factor Receptor Expression through the Activation of Notch1 in Non-Small Cell Lung Cancer

Antifungal Therapy with Itraconazole Impairs the Anti-Lymphoma Effects of Rituximab by Inhibiting Recruitment of CD20 to Cell Surface Lipid Rafts

Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma

Histone Deacetylase Inhibitors Induce a Very Broad, Pleiotropic Anticancer Drug Resistance Phenotype in Acute Myeloid Leukemia Cells by Modulation of Multiple ABC Transporter Genes

FMS-Like Tyrosine Kinase 3―Internal Tandem Duplication Tyrosine Kinase Inhibitors Display a Nonoverlapping Profile of Resistance Mutations In vitro

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy

Imatinib and leptomycin B are effective in overcoming imatinib-resistance due to Bcr-Abl amplification and clonal evolution but not due to Bcr-Abl kinase domain mutation

GM1 Expression of Non-Hodgkin's Lymphoma Determines Susceptibility to Rituximab Treatment

Aktive Filter

Suchergebnisse filtern